Anebulo Pharmaceuticals, Inc. (ANEB)
ANEB has a market cap or net worth of $97.81 million. The enterprise value is $81.27 million.
The latest earnings date was Monday, June 20, 2022, before market open.
|Last Earnings Date||Jun 20, 2022|
ANEB has 23.34 million shares outstanding. The number of shares has increased by 79.82% in one year.
|Shares Change (YoY)||+79.82%|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||75.55%|
|Owned by Institutions (%)||20.98%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 201.09, with a Debt / Equity ratio of 0.00.
|Debt / Equity||0.00|
|Debt / EBITDA||0.00|
|Debt / FCF||0.00|
Return on equity (ROE) is -173.80% and return on invested capital (ROIC) is -3,703.10%.
|Return on Equity (ROE)||-173.80%|
|Return on Assets (ROA)||-171.60%|
|Return on Capital (ROIC)||-3,703.10%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$16.81M|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-40.31%|
|50-Day Moving Average||3.88|
|200-Day Moving Average||4.94|
|Average Volume (30 Days)||17,191|
Short Selling Information
The latest short interest is 10,528, so 0.05% of the outstanding shares have been sold short.
|Short % of Shares Out||0.05%|
|Short % of Float||0.45%|
|Short Ratio (days to cover)||0.44|
|Earnings Per Share (EPS)||-$1.55|
The company has $16.55 million in cash and no debt, giving a net cash position of $16.55 million or $0.71 per share.
|Cash & Cash Equivalents||16.55M|
|Net Cash Per Share||$0.71|
|Book Value Per Share||0.74|
|Operating Cash Flow||-6.54M|
|Free Cash Flow||-6.54M|
|FCF Per Share||n/a|
Dividends & Yields
ANEB does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for ANEB is $8.16, which is 94.75% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||94.75%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|